Are Julmust and Lucozade both energy drinks?
Julmust Julmust (Swedish: "jul" "Yule" and "must " "not yet fermented juice of fruit or berries", though there is no such juice in "julmust") is a soft drink that is mainly consumed in Sweden around Christmas. During the other part of the year it is usually quite difficult to find in stores, but sometimes it is sold at other times of the year under the name "must". At Easter the name is påskmust (from "påsk ", "Easter" / "Paschal" ["q.v."]). The content is the same regardless of the marketing name, although the length of time it is stored before bottling differs; however, the beverage is more closely associated with Christmas, somewhat less with Easter and traditionally not at all with the summer. 45 million litres of "julmust" are consumed during December, which is around 50% of the total soft drink volume in December and 75% of the total yearly must sales.
Exenatide Exenatide (marketed as Byetta, Bydureon) is a glucagon-like peptide-1 agonist (GLP-1 agonist) medication, belonging to the group of incretin mimetics, approved in April 2005 for the treatment of diabetes mellitus type 2. Exenatide in its Byetta form is administered as a subcutaneous injection (under the skin) of the abdomen, thigh, or arm, any time within the 60 minutes before the first and last meal of the day. A once-weekly injection has been approved as of January 27, 2012 under the trademark Bydureon. It is manufactured by Amylin Pharmaceuticals and commercialized by AstraZeneca.